Acarbose
- Product NDC
- 62135-455
- 11-digit product format
- 621350455
- Labeler code
- 62135
- Product ID
- 62135-455_458bb3c6-f92c-cf49-e063-6294a90a96c2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- acarbose
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA202271
- Marketing category
- ANDA
- Marketing start
- 2021-04-16
- Substance
- ACARBOSE
- Active strength
- 100 mg/1
- Pharmacologic classes
- alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Acarbose
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ACARBOSE | 100 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | T58MSI464G |
| Rxcui | 199149, 199150, 200132 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62135-455-90 | Acarbose | 90 in 1 BOTTLE | TABLET | 90 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62135-455 | ACARBOSE TABLET [CHARTWELL RX, LLC] | 2 | Current NDC, 1 package rows | 20241012_d1b627e1-d78d-47dd-93f5-2bf4998466ba.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 62135-455-90 | 62135045590 | 90 TABLET in 1 BOTTLE (62135-455-90) | 90 tablet | 2023-01-31 | No | No | Current |